Aix-Marseille Université, INSERM UMR1106, Institut de Neurosciences des Systèmes, Marseille, France.
Gladstone Institute of Neurological Disease, 1650 Owens Street, San Francisco, California, 94158, USA.
J Neurosci Res. 2017 Nov;95(11):2217-2235. doi: 10.1002/jnr.24064. Epub 2017 May 2.
Hypometabolism, characterized by decreased brain glucose consumption, is a common feature of many neurodegenerative diseases. Initial hypometabolic brain state, created by characteristic risk factors, may predispose the brain to acquired epilepsy and sporadic Alzheimer's and Parkinson's diseases, which are the focus of this review. Analysis of available data suggests that deficient glucose metabolism is likely a primary initiating factor for these diseases, and that resulting neuronal dysfunction further promotes the metabolic imbalance, establishing an effective positive feedback loop and a downward spiral of disease progression. Therefore, metabolic correction leading to the normalization of abnormalities in glucose metabolism may be an efficient tool to treat the neurological disorders by counteracting their primary pathological mechanisms. Published and preliminary experimental results on this approach for treating Alzheimer's disease and epilepsy models support the efficacy of metabolic correction, confirming the highly promising nature of the strategy. © 2017 Wiley Periodicals, Inc.
代谢低下,其特征是大脑葡萄糖消耗减少,是许多神经退行性疾病的共同特征。由特征性风险因素引起的初始代谢低下的脑状态可能使大脑容易发生获得性癫痫和散发性阿尔茨海默病和帕金森病,这是本综述的重点。对现有数据的分析表明,葡萄糖代谢不足可能是这些疾病的主要起始因素,而由此导致的神经元功能障碍进一步促进了代谢失衡,建立了一个有效的正反馈循环和疾病进展的下降螺旋。因此,通过纠正代谢异常使葡萄糖代谢恢复正常可能是通过对抗主要病理机制来治疗神经紊乱的有效手段。关于该方法治疗阿尔茨海默病和癫痫模型的已发表和初步实验结果支持代谢纠正的疗效,证实了该策略具有很高的前景。© 2017 年 Wiley 期刊,Inc.